{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:53:01Z","timestamp":1791309181727,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To investigate the longitudinal association of different phenotypes of diabetes and obesity with the incidence of cardiovascular disease (CVD), CVD- and all-cause mortality. A total of 5432 adults, aged\u2009\u2265\u200935\u00a0years and free of CVD were included in this cohort study. Diabesity phenotypes were defined in six categories based on the presence of diabetes (normal (NG), prediabetes and diabetes) and obesity (obese, non-obese). Fasting blood sugar, 2-h post prandial glucose, or using anti-diabetic medicines were used to define diabetes, and body mass index and waist circumference were used to define obesity. Cox proportional hazards models were used to estimate hazard ratios (HRs) for incident CVD, CVD- and all-cause mortality across these categories. After a median follow-up of 11.25\u00a0years, 819 CVD cases, 181 CVD deaths and 488 all-cause deaths occurred. In multivariable-adjusted models and irrespective of obesity definition, the phenotypes of normal glucose-obese, prediabetes-obese and pre-diabetes-non obese were not associated with CVD incidence in comparison with NG-non obese phenotype, however, the phenotypes of diabesity, either defined by general or abdominal obesity, were associated with increased risk of incident CVD events (HR\u2009=\u20091.42, 95% CI 1.01, 1.99, and HR\u2009=\u20091.46, 95% CI 1.07, 1.98, respectively). These findings were sex-specific and only in men with a phenotype of abdominal obesity-diabetes, a positive link was observed for CVD incidence (HR\u2009=\u20091.60, 95% CI 1.01, 2.52). No significant association was found between diabesity and death from CVD or all causes. Diabesity is a predictor of CVD and stroke incidence, but not CVD or all-cause mortality, among Iranians. This association is more pronounced amongst men than women.<\/jats:p>","DOI":"10.1038\/s41598-023-38221-7","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:02:23Z","timestamp":1689152543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality"],"prefix":"10.1038","volume":"13","author":[{"given":"Kamran","family":"Mehrabani-Zeinabad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Haghighatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Najafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Boshtam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagfinn","family":"Aune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"38221_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"38221_CR2","doi-asserted-by":"publisher","DOI":"10.4081\/jphr.2021.2475","author":"F Pourfarzi","year":"2021","unstructured":"Pourfarzi, F. et al. Prevalence of overweight and obesity in Iranian population: A population-based study in northwestern of Iran. J. Public Health Res. https:\/\/doi.org\/10.4081\/jphr.2021.2475 (2021).","journal-title":"J. Public Health Res."},{"issue":"11","key":"38221_CR3","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s13300-021-01152-5","volume":"12","author":"ME Khamseh","year":"2021","unstructured":"Khamseh, M. E. et al. Nationwide prevalence of diabetes and prediabetes and associated risk factors among Iranian adults: Analysis of data from PERSIAN cohort study. Diabetes Ther. 12(11), 2921\u20132938 (2021).","journal-title":"Diabetes Ther."},{"key":"38221_CR4","unstructured":"World Health Organization. Obesity and overweight. Updated June 9, 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 7 December 2021."},{"issue":"6","key":"38221_CR5","doi-asserted-by":"publisher","first-page":"e22479","DOI":"10.5812\/ircmj.17(6)2015.22479","volume":"17","author":"E Bakhshi","year":"2015","unstructured":"Bakhshi, E. et al. Obesity and related factors in Iran: The STEPS Survey, 2011. Iran. Red Crescent Med. J. 17(6), e22479 (2015).","journal-title":"Iran. Red Crescent Med. J."},{"key":"38221_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fendo.2020.00042","volume":"11","author":"S Djalalinia","year":"2020","unstructured":"Djalalinia, S. et al. Patterns of obesity and overweight in the Iranian population: Findings of STEPs 2016. Front. Endocrinol. (Lausanne) 11, 42 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"38221_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"ERF Collaboration","year":"2011","unstructured":"Collaboration, E. R. F. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364(9), 829\u2013841 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"38221_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88\u201398 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"38221_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.115.016801","volume":"133","author":"D Aune","year":"2016","unstructured":"Aune, D. et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: A systematic review and dose\u2013response meta-analysis of prospective studies. Circulation 133(7), 639\u2013649 (2016).","journal-title":"Circulation"},{"issue":"6","key":"38221_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ejcn.2013.61","volume":"67","author":"S Carmienke","year":"2013","unstructured":"Carmienke, S. et al. General and abdominal obesity parameters and their combination in relation to mortality: A systematic review and meta-regression analysis. Eur. J. Clin. Nutr. 67(6), 573\u2013585 (2013).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"9","key":"38221_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1017\/S0007114521000064","volume":"126","author":"R Xue","year":"2021","unstructured":"Xue, R. et al. Abdominal obesity and risk of CVD: A dose\u2013response meta-analysis of thirty-one prospective studies. Br. J. Nutr. 126(9), 1420\u20131430 (2021).","journal-title":"Br. J. Nutr."},{"issue":"6","key":"38221_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.nut.2013.10.021","volume":"30","author":"F Haghighatdoost","year":"2014","unstructured":"Haghighatdoost, F. et al. Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults. Nutrition 30(6), 636\u2013644 (2014).","journal-title":"Nutrition"},{"key":"38221_CR13","unstructured":"Chadt, A., et al., Molecular links between Obesity and Diabetes: \u201cDiabesity\u201d, in Endotext, K.R. Feingold, et al., Editors. 2000, MDText.com, Inc. Copyright \u00a9 2000\u20132022, MDText.com, Inc.: South Dartmouth (MA)."},{"issue":"14","key":"38221_CR14","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.3390\/ijms23147886","volume":"23","author":"D Garc\u00eda-Vega","year":"2022","unstructured":"Garc\u00eda-Vega, D., Gonz\u00e1lez-Juanatey, J. R. & Eiras, S. Diabesity in elderly cardiovascular disease patients: Mechanisms and regulators. Int. J. Mol. Sci. 23(14), 7886 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"38221_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamacardio.2016.1702","volume":"1","author":"F Bragg","year":"2016","unstructured":"Bragg, F. et al. Association of random plasma glucose levels with the risk for cardiovascular disease among chinese adults without known diabetes. JAMA Cardiol. 1(7), 813\u2013823 (2016).","journal-title":"JAMA Cardiol."},{"issue":"8","key":"38221_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/oby.23465","volume":"30","author":"L Kong","year":"2022","unstructured":"Kong, L. et al. Diabesity phenotype and the risks of cardiovascular disease and subclinical atherosclerosis: A prospective cohort study. Obesity (Silver Spring) 30(8), 1681\u20131690 (2022).","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"38221_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/jhh.2010.99","volume":"25","author":"N Sarrafzadegan","year":"2011","unstructured":"Sarrafzadegan, N. et al. The Isfahan cohort study: Rationale, methods and main findings. J. Hum. Hypertens. 25(9), 545\u2013553 (2011).","journal-title":"J. Hum. Hypertens."},{"key":"38221_CR18","unstructured":"https:\/\/www.cdc.gov\/obesity\/basics\/adult-defining.html#:~:text=Adult%20Body%20Mass%20Index&text=If%20your%20BMI%20is%20less,falls%20within%20the%20obesity%20range."},{"key":"38221_CR19","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735\u20132752 (2005).","journal-title":"Circulation"},{"key":"38221_CR20","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes, 2022. 40(1): p. 10\u201338.","DOI":"10.2337\/cd22-as01"},{"issue":"20","key":"38221_CR21","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","volume":"108","author":"RV Luepker","year":"2003","unstructured":"Luepker, R. V. et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108(20), 2543\u20132549 (2003).","journal-title":"Circulation"},{"key":"38221_CR22","unstructured":"R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/."},{"key":"38221_CR23","unstructured":"Therneau T (2022). _A Package for Survival Analysis in R_. R package version 3.3\u20131, https:\/\/CRAN.R-project.org\/package=survival."},{"issue":"24","key":"38221_CR24","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel, A. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358(24), 2560\u20132572 (2008).","journal-title":"N. Engl. J. Med."},{"key":"38221_CR25","doi-asserted-by":"publisher","first-page":"282089","DOI":"10.1155\/2014\/282089","volume":"2014","author":"M Bozorgmanesh","year":"2014","unstructured":"Bozorgmanesh, M., Arshi, B., Sheikholeslami, F., Azizi, F. & Hadaegh, F. No obesity paradox-BMI incapable of adequately capturing the relation of obesity with all-cause mortality: An inception diabetes cohort study. Int. J. Endocrinol. 2014, 282089 (2014).","journal-title":"Int. J. Endocrinol."},{"issue":"42","key":"38221_CR26","doi-asserted-by":"publisher","first-page":"18226","DOI":"10.1073\/pnas.1005259107","volume":"107","author":"YD Tchoukalova","year":"2010","unstructured":"Tchoukalova, Y. D. et al. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc. Natl. Acad. Sci. U. S. A. 107(42), 18226\u201318231 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"38221_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijcard.2011.08.049","volume":"165","author":"S Samadi","year":"2013","unstructured":"Samadi, S. et al. Hypertriglyceridemic waist: The point of divergence for prediction of CVD vs. mortality: Tehran lipid and glucose study. Int. J. Cardiol. 165(2), 260\u20135 (2013).","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"38221_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00075197-200111000-00006","volume":"4","author":"E Blaak","year":"2001","unstructured":"Blaak, E. Gender differences in fat metabolism. Curr. Opin. Clin. Nutr. Metab. Care 4(6), 499\u2013502 (2001).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"38221_CR29","doi-asserted-by":"publisher","first-page":"100277","DOI":"10.1016\/j.lanwpc.2021.100277","volume":"17","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. Age-specific modifiable risk factor profiles for cardiovascular disease and all-cause mortality: A nationwide, population-based, prospective cohort study. Lancet Reg. Health West Pac. 17, 100277 (2021).","journal-title":"Lancet Reg. Health West Pac."},{"issue":"14","key":"38221_CR30","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.3390\/ijms23147886","volume":"23","author":"D Garc\u00eda-Vega","year":"2022","unstructured":"Garc\u00eda-Vega, D., Gonz\u00e1lez-Juanatey, J. R. & Eiras, S. Diabesity in elderly cardiovascular disease patients: Mechanisms and regulators. Int. J. Mol. Sci. 23(14), 7886 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"38221_CR31","first-page":"00134","volume":"S0033\u20130620","author":"AW Tutor","year":"2022","unstructured":"Tutor, A. W., Lavie, C. J., Kachur, S., Milani, R. V. & Ventura, H. O. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog. Cardiovasc. Dis. S0033\u20130620(22), 00134\u201300137 (2022).","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"5","key":"38221_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.mayocp.2012.01.013","volume":"87","author":"PA McAuley","year":"2012","unstructured":"McAuley, P. A. et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin. Proc. 87(5), 443\u2013451 (2012).","journal-title":"Mayo Clin. Proc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38221-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38221-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38221-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T21:02:38Z","timestamp":1689195758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38221-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38221"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38221-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11266"}}